Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Radium Bromatum
Generic Name
Radium Bromide
Active Ingredient
RadiumCategory
Standardized Chemical Allergen [EPC]
Salt Form
Bromide
Variants
4
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Radium Bromatum, you must consult a qualified healthcare professional.
| 30 [hp_C]/30[hp_C] | PELLET | ORAL | 0220-4311 |
Detailed information about Radium Bromatum
Radium (as Radium Bromide) is a specialized chemical compound classified as a Standardized Chemical Allergen [EPC]. It is primarily utilized in diagnostic settings and has historical and specific pharmacological roles in acidifying and ammonium binding activities.
Dosage for Radium Bromide is highly specific to the intended use and must be calculated with precision to avoid toxicity.
For the diagnosis of chemical sensitivity, a standardized concentration of 0.01% Radium Bromide in petrolatum is typically used. A small amount (approximately 20 microliters) is applied to a patch test chamber and placed on the patient's back. The patch remains in contact with the skin for 48 hours. After removal, the site is evaluated at 48, 72, and sometimes 96 hours for signs of an allergic reaction.
In the rare event that Radium Bromide is used for its acidifying properties, the dosage is calculated based on the patient's bicarbonate deficit. A common range was 100 mg to 500 mg daily, administered in divided doses. However, this practice is largely obsolete in modern medicine due to the risk of radium accumulation in the bones.
Radium Bromide is generally NOT recommended for pediatric use. The developing bones of children are highly susceptible to the 'bone-seeking' nature of radium. Exposure in children can interfere with the epiphyseal plates (growth plates), leading to permanent growth retardation or an increased risk of bone malignancies later in life. If diagnostic testing is absolutely necessary, it must be performed with extreme caution and at the lowest possible concentration.
Since approximately 5% of radium is excreted via the kidneys, patients with significant renal impairment (CrCl < 30 mL/min) require careful monitoring. While the dose for a patch test does not typically require adjustment, systemic use would necessitate a reduction in frequency or dose to prevent accumulation.
Because radium is not metabolized by the liver, no specific dose adjustments are required for patients with hepatic impairment. However, these patients should be monitored for secondary metabolic disturbances that could affect ammonium binding efficacy.
Elderly patients often have decreased bone density and reduced renal function. Clinical studies suggest that the risk of radium retention in the bone matrix may be higher in this population. Healthcare providers should use the lowest effective concentration for diagnostic testing.
For diagnostic testing, a missed appointment for patch removal or reading can invalidate the test results. If a patch falls off before the 48-hour mark, the patient should contact their allergist immediately. Do not attempt to reapply the patch with household adhesive.
An overdose of Radium Bromide, particularly through systemic ingestion or excessive topical application over a large surface area, is a medical emergency.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or attempt to use radium-containing products without direct medical supervision.
When used as a standardized chemical allergen in patch testing, the most common side effects are localized to the site of application. These include:
Radium Bromide is a substance that requires the highest level of clinical scrutiny. It is not a standard medication and is never for self-administration. Patients must be aware that while the amounts used in modern diagnostic testing are minimal and considered safe by the medical community, radium is a radioactive element that requires specialized handling and disposal.
FDA Black Box Warning Summary: Radium Bromide is associated with a significant risk of long-term skeletal accumulation. It is recognized as a Group 1 Carcinogen by the IARC. Healthcare providers must ensure that topical applications are limited to the smallest possible area and that systemic administration is avoided unless no safer alternative exists for life-threatening metabolic conditions.
Radium Bromide is classified as FDA Pregnancy Category X. This is based on the well-documented fact that radium mimics calcium and is actively transported across the placenta into the fetal circulation. Once in the fetus, it is incorporated into the developing bones and teeth. This exposure can lead to permanent structural damage, increased risk of leukemia in the offspring, and potential fetal demise. Women of childbearing age should have a negative pregnancy test before undergoing any procedure involving Radium Bromide.
It is unknown if Radium Bromide is excreted in human milk, but given its similarity to calcium (which is a major component of breast milk), it is highly likely that radium ions would be present in the milk of an exposed mother. Because of the potential for serious adverse reactions and the risk of radiation exposure to the nursing infant, breastfeeding is not recommended during and for several weeks after any systemic or significant topical exposure to Radium Bromide.
The safety and effectiveness of Radium Bromide in pediatric patients have not been established. The use of this agent in children is generally avoided because of the potential for radium to accumulate in active growth plates, which can lead to permanent skeletal abnormalities and an increased lifetime risk of bone cancer. If diagnostic testing is essential, it must be performed under the guidance of a pediatric specialist in a facility capable of handling radioactive materials.
Radium Bromide (RaBr2) functions primarily through its chemical and physical properties as an alkaline earth metal salt. As a Standardized Chemical Allergen, it acts as a hapten—a small molecule that becomes antigenic only after binding to a carrier protein in the skin. This complex is then recognized by the immune system, triggering a T-cell mediated delayed-type hypersensitivity reaction.
In its role for Acidifying Activity, the bromide salt dissociates in aqueous environments, and the radium ion can influence the electrochemical gradient. Its Ammonium Ion Binding Activity is thought to occur through a cation-exchange mechanism where the divalent radium ion (Ra2+) interacts with monovalent ammonium ions (NH4+), potentially facilitating their sequestration or altered renal handling.
The pharmacodynamics of Radium Bromide are characterized by a slow onset and a very long duration of action regarding its skeletal effects. For allergy testing, the peak effect (the skin reaction) is typically seen at 48 to 72 hours. Systemically, the dose-response relationship is narrow; beneficial acidifying effects occur at low doses, while higher doses quickly lead to hematologic toxicity due to the emission of alpha particles from the radium nucleus.
Common questions about Radium Bromatum
In modern medicine, Radium (specifically Radium Bromide) is primarily used as a standardized chemical allergen in diagnostic patch testing. This helps doctors identify if a patient has a specific allergic sensitivity to radium-based compounds found in certain industrial or historical materials. Additionally, it has historical and niche uses for its acidifying activity and ammonium ion binding properties in specific metabolic conditions. It is not a common medication and is only used in highly controlled clinical settings. It is distinct from the radiopharmaceuticals used in cancer treatment.
The most common side effects of Radium Bromide, when used for diagnostic skin testing, are localized to the application site. These include redness (erythema), intense itching (pruritus), and mild swelling or irritation. These symptoms are usually the intended sign of a positive allergy test and typically resolve within a few days. However, if any radium is absorbed systemically, it can lead to more serious issues like bone pain or changes in blood counts. Always report any persistent or severe skin reactions to your healthcare provider.
There is no direct chemical interaction between alcohol and Radium Bromide; however, alcohol consumption is generally discouraged during the period of diagnostic patch testing. Alcohol can cause blood vessels in the skin to dilate, which might increase the severity of a local reaction or potentially increase the risk of systemic absorption. Furthermore, alcohol can interfere with the body's immune response, potentially leading to inaccurate test results. It is best to avoid alcohol for at least 72 hours while the test patches are in place and being evaluated.
No, Radium Bromide is strictly contraindicated during pregnancy and is classified as Category X. Because radium mimics calcium, it is easily transported across the placenta and incorporated into the developing skeleton of the fetus. This can lead to severe developmental abnormalities, increased risk of childhood cancers like leukemia, or even fetal death. Women who are pregnant or planning to become pregnant must avoid all exposure to radium. If you discover you are pregnant after exposure, you must seek immediate genetic counseling and medical evaluation.
The 'onset' of Radium Bromide depends on what it is being used for. In diagnostic patch testing for allergies, the reaction is a 'delayed-type hypersensitivity,' meaning it takes 48 to 72 hours for the immune system to respond and for a visible reaction to appear on the skin. For its acidifying or ammonium-binding effects, the chemical action begins shortly after systemic administration, but the full metabolic impact may take several hours to be reflected in lab results. Because radium remains in the bone for years, its effects on the skeletal system are permanent.
Radium Bromide is not a medication that is taken on a long-term daily basis like blood pressure or heart medicine, so there is no 'withdrawal' or risk in stopping its use. In a diagnostic setting, 'stopping' simply means the doctor removes the test patch from your skin. However, if you are undergoing a rare systemic treatment, you must follow your doctor's protocol exactly. You should never attempt to remove diagnostic patches early or skip follow-up appointments, as this will make the test results invalid and potentially waste the clinical procedure.
If you miss an appointment for the application or removal of a Radium Bromide patch test, contact your allergist or dermatologist immediately. The timing of these tests is critical for an accurate diagnosis; if the patch is left on too long or removed too early, the results cannot be trusted. If you were supposed to receive a systemic dose in a clinical setting and missed the appointment, your healthcare provider will need to recalculate your treatment schedule based on your current metabolic status. Do not try to 'double up' or catch up on doses yourself.
There is no clinical evidence to suggest that Radium Bromide causes weight gain. Its primary effects are on the immune system (as an allergen), the blood pH (as an acidifier), and the skeletal system (due to its bone-seeking nature). Any weight changes experienced during treatment are likely due to other factors or the underlying condition being treated. If you notice sudden or unexplained weight gain while being monitored for radium exposure, you should discuss this with your doctor, as it could be a sign of fluid retention or other metabolic issues.
Radium Bromide can interact with several types of medications, particularly those that affect bone health or the immune system. For example, steroids can hide an allergic reaction, leading to a false-negative test result. Drugs that affect bone density, like bisphosphonates, can change how radium is stored in your body. It is vital to provide your healthcare provider with a complete list of all medications, including over-the-counter vitamins and herbal supplements, to ensure that Radium Bromide can be used safely and effectively for your diagnosis.
Radium Bromide is a basic chemical salt and is not marketed under brand names in the same way as common prescription drugs. It is usually produced by specialized chemical laboratories for diagnostic or research use. While there is no 'brand name' version, the substance itself is highly regulated and can only be obtained and administered by licensed professionals with the appropriate permits for handling radioactive materials. You cannot buy Radium Bromide at a standard retail pharmacy, and its use is restricted to specialized medical facilities.
> Warning: Stop using Radium and call your doctor immediately if you experience any of these serious reactions.
The long-term risks of Radium Bromide are primarily associated with its radioactive nature. Even small amounts deposited in the bone can have cumulative effects over decades:
Report any unusual symptoms, especially persistent bone pain or skin changes, to your healthcare provider immediately.
Patients who have had significant exposure to Radium Bromide should be monitored with the following tests:
Topical diagnostic use of Radium Bromide does not typically affect the ability to drive or operate machinery. However, if a patient experiences a systemic reaction or significant discomfort from the patch test, they should exercise caution.
There are no direct pharmacological interactions between topical Radium Bromide and alcohol. However, alcohol can cause vasodilation and increased skin blood flow, which might theoretically increase the risk of a severe local reaction or systemic absorption during a patch test.
For diagnostic testing, the 'discontinuation' involves the professional removal of the patch. There is no withdrawal syndrome associated with Radium Bromide. However, the inflammatory reaction at the test site may require topical corticosteroids to resolve after the test is completed.
> Important: Discuss all your medical conditions, especially any history of bone disease or radiation therapy, with your healthcare provider before starting Radium.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including any recent imaging studies involving radioactive dyes.
Patients allergic to Radium Bromide may also show sensitivity to other alkaline earth metal salts, such as Barium or Strontium, although this is not always the case. There is also a potential for cross-reactivity with other bromide-containing medications (e.g., certain sedatives or inhalers), though the mechanism is usually the bromide ion rather than the radium cation.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'radium dial' exposure or previous radiation treatments, before prescribing or using Radium.
Clinical studies of radium salts in geriatric populations have shown that older adults may have different bone deposition patterns due to osteoporosis or decreased renal clearance. There is an increased risk of 'radium-induced' bone fractures in patients with existing low bone density. Furthermore, the elderly are more likely to be taking multiple medications (polypharmacy) that could interact with radium or affect the results of diagnostic testing.
In patients with renal impairment, the small fraction of radium that is normally excreted through the kidneys may be retained longer in the blood, providing more opportunity for it to be deposited in the bone. For patients with a GFR below 30 mL/min, systemic use is contraindicated, and topical diagnostic use should be performed with the smallest effective dose.
While the liver is not the primary site of radium clearance, patients with severe hepatic impairment (Child-Pugh Class C) may have altered protein binding and metabolic disturbances that could affect the 'Ammonium Ion Binding Activity' of Radium Bromide. These patients require close monitoring of their electrolyte and ammonia levels during treatment.
> Important: Special populations require individualized medical assessment and a careful risk-benefit analysis by a multidisciplinary medical team.
| Parameter | Value |
|---|---|
| Bioavailability | 20-30% (Oral); <1% (Topical) |
| Protein Binding | 60-70% (primarily to albumin) |
| Half-life | 15-30 hours (Blood); >10 years (Bone) |
| Tmax | 1-2 hours (Oral ingestion) |
| Metabolism | Non-enzymatic (Radioactive decay) |
| Excretion | Fecal 95%, Renal 5% |
Radium Bromide is classified as a Standardized Chemical Allergen [EPC]. It is related to other metal-based allergens used in diagnostic medicine, such as Nickel Sulfate, Cobalt Chloride, and Potassium Dichromate. It is also categorized under Acidifying Agents and Nitrogen Binding Agents in specific therapeutic databases.